Cargando…
Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
BACKGROUND: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controversial. This study is aimed at estimating cancer risk in MS patients. METHODS: Nested case–control study using data collected between 01/01/1987 and 28/02/2016 from the United Kingdom Clinical Practice...
Autores principales: | Zecca, Chiara, Disanto, Giulio, Sacco, Rosaria, MacLachlan, Sharon, Kuhle, Jens, Ramagopalan, Sreeram V., Gobbi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914231/ https://www.ncbi.nlm.nih.gov/pubmed/33084939 http://dx.doi.org/10.1007/s00415-020-10170-5 |
Ejemplares similares
-
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
por: Scotti, Barbara, et al.
Publicado: (2018) -
Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
por: Zecca, Chiara, et al.
Publicado: (2019) -
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica
por: Eisler, Jennifer Jessica, et al.
Publicado: (2023) -
Real‐world evaluation of ocrelizumab in multiple sclerosis: A systematic review
por: Montalban, Xavier, et al.
Publicado: (2023) -
Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021)